Analyst Reco. MedinCell S.A.

Equities

MEDCL

FR0004065605

Pharmaceuticals

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-02-09 am EST			After hours 03:32:33 pm
24.32 ^EUR	+2.36%		24.33	+0.04%

Jan. 29	Modest Recovery for Medincell Following Sharp Decline
Jan. 28	Medincell S.A. Reports Sales Results for the Fourth Quarter and Full 2025	CI

Analyst Reco.

Jan. 29	Modest Recovery for Medincell Following Sharp Decline
Jan. 19	MedinCell S.A.: One to Watch Today
Jan. 16	MedinCell, Biggest Gainer on the SBF 120 at Friday's Close, January 16, 2026
Jan. 16	Medincell Buoyed by Positive Oddo BHF Rating
Nov. 10	Medincell Joins MSCI World Small Cap Index
25-10-13	Medincell: FDA approves expanded indication for Uzedy	RE
25-10-10	Teva Pharmaceuticals and Medincell Announce FDA Approves Expanded Indication for UZEDY®? (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder	CI
25-09-11	On the stock market, inflation pushes Oracle off the front page.
24-01-05	MedinCell: share price continues to rise, Jefferies to buy
23-03-21	MedinCell: share price surges, broker in support
23-03-21	MedinCell: Oddo raises its target price on the stock

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Filters

Rankings

Rankings

Currency / Forex

Currencies & Forex

Commodities

Cryptocurrencies

Cryptocurrencies

Interest Rates

Interest Rates Area

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

Optimize my profits